Vista Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE427C01021
  • NSEID:
  • BSEID: 524711
INR
5.80
-0.15 (-2.52%)
BSENSE

Sep 08, 03:30 PM

BSE+NSE Vol: 33.78 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 384463,
    "name": "Vista Pharma.",
    "stock_name": "Vista Pharma.",
    "full_name": "Vista Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/vista-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5.80",
    "chg": -0.15,
    "chgp": "-2.52%",
    "dir": -1,
    "prev_price": "5.95",
    "mcapval": "37.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524711,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE427C01021",
    "curr_date": "Sep 08, 03:30 PM",
    "curr_time": "19:50 PM",
    "last_traded_at": "Sep 08, 03:30 PM IST",
    "bse_nse_vol": "33.78 k",
    "exc_status": "Active",
    "traded_date": "Sep 08, 2026",
    "traded_date_str": "2026 09 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vista-pharma-384463-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs 5.5 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-ltd-stock-falls-to-52-week-low-of-rs55-4186820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VistaPharmaceut_priceRelatedfactors_4186820.png",
        "date": "2026-09-08 14:45:14",
        "description": "For the second consecutive session, Vista Pharmaceuticals Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 5.5 on 8 Sep 2026. This latest drop extends the stock’s downward trajectory, which has now resulted in a 5.41% loss over just two days, underscoring persistent selling pressure amid broader market weakness."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4171508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VistaPharmaceut_mojoScore_4171508.png",
        "date": "2026-08-27 10:10:22",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the company’s current position as of 27 August 2026, providing investors with the latest insights into the stock’s performance and outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4150077",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VistaPharmaceut_mojoScore_4150077.png",
        "date": "2026-08-12 10:11:22",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024, but the analysis below reflects the stock’s current position as of 12 August 2026, incorporating the latest fundamentals, returns, and financial metrics available today."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4125762",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VistaPharmaceut_mojoScore_4125762.png",
        "date": "2026-07-29 10:10:57",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Jul 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4103704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VistaPharmaceut_mojoScore_4103704.png",
        "date": "2026-07-15 10:10:33",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4081545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VistaPharmaceut_mojoScore_4081545.png",
        "date": "2026-07-01 10:10:22",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Jul 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 01 July 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4061061",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VistaPharmaceut_mojoScore_4061061.png",
        "date": "2026-06-18 10:10:34",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Jul 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 18 June 2026, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 5728,
    "sid": "384463",
    "stock_news_url": "https://www.marketsmojo.com/news/vista-pharmaceuticals-384463"
  },
  "announcements": [
    {
      "caption": "Results For The Quarter Ended 30.06.2026",
      "datetime": "14-Aug-2026",
      "details": "Results for the quarter ended 30.06.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Results For The Quarter Ended 30.06.2026",
      "datetime": "14-Aug-2026",
      "details": "Results for the quarter ended 30.06.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approval Of Un Audited Financials Results For The Quarter Ended 30.06.2026",
      "datetime": "13-Aug-2026",
      "details": "Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. Unaudited financial results for the quarter ended 30.06.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Results For The Quarter Ended 30.06.2026

14-Aug-2026 | Source : BSE

Results for the quarter ended 30.06.2026

Board Meeting Outcome for Results For The Quarter Ended 30.06.2026

14-Aug-2026 | Source : BSE

Results for the quarter ended 30.06.2026

Board Meeting Intimation for Approval Of Un Audited Financials Results For The Quarter Ended 30.06.2026

13-Aug-2026 | Source : BSE

Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. Unaudited financial results for the quarter ended 30.06.2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available